The RND1 Small GTPase: Main Functions and Emerging Role in Oncogenesis

• Published in: International journal of molecular sciences Vol. 20; no. 15
• Main Authors: Mouly, Laetitia, Gilhodes, Julia, Lemarié, Anthony, Cohen-Jonathan Moyal, Elizabeth, Toulas, Christine, Favre, Gilles, Sordet, Olivier, Monferran, Sylvie
• Format: Journal Article
• Language: English
• Published: MDPI 24.07.2019
• Subjects: Life Sciences; response to anticancer agents; prognosis factor; oncogenesis; migration; RND; Rho GTPase
• ISSN: 1661-6596; 1422-0067
• DOI: 10.3390/ijms20153612

The Rho GTPase family can be classified into classic and atypical members. Classic members cycle between an inactive Guanosine DiPhosphate -bound state and an active Guanosine TriPhosphate-bound state. Atypical Rho GTPases, such as RND1, are predominantly in an active GTP-bound conformation. The role of classic members in oncogenesis has been the subject of numerous studies, while that of atypical members has been less explored. Besides the roles of RND1 in healthy tissues, recent data suggest that RND1 is involved in oncogenesis and response to cancer therapeutics. Here, we present the current knowledge on RND1 expression, subcellular localization, and functions in healthy tissues. Then, we review data showing that RND1 expression is dysregulated in tumors, the molecular mechanisms involved in this deregulation, and the role of RND1 in oncogenesis. For several aggressive tumors, RND1 presents the features of a tumor suppressor gene. In these tumors, low expression of RND1 is associated with a bad prognosis for the patients. Finally, we highlight that RND1 expression is induced by anticancer agents and modulates their response. Of note, RND1 mRNA levels in tumors could be used as a predictive marker of both patient prognosis and response to anticancer agents.